Importer of Controlled Substances Application: PHARMACORE, 22553 [2015-09332]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices
Controlled substance
Schedule
Nabilone (7379) ............................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium, powdered (9639) .............
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for this drug code is authorized for this
registration.
Dated: April 14, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–09344 Filed 4–21–15; 8:45 am]
4-Anilino-N-phenethyl-4-piperidine
(ANPP) (8333) ..........................
Remifentanil (9739) ......................
Fentanyl (9801) ............................
Importer of Controlled Substances
Application: PHARMACORE
Notice of application.
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
May 22, 2015. Such persons may also
file a written request for a hearing on
the application pursuant to 21 CFR
1301.43 on or before May 22, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments
and requests for any hearings on
DATES:
Jkt 235001
II
II
II
Dated: April 14, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–09332 Filed 4–21–15; 8:45 am]
[Docket No. DEA–392]
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Schedule
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
18:00 Apr 21, 2015
Controlled substance
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Regarding the drug code (8333), the
company plans to manufacture this
listed controlled substance for
commercial sale.
Dated: April 14, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
DEPARTMENT OF JUSTICE
VerDate Sep<11>2014
manufacturer of certain basic classes of
controlled substances. No comments or
objections were submitted to this notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823(a) and
determined that the registration of
Cedarburg Pharmaceuticals, Inc. to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed:
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
ACTION:
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispenser,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix of subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on August
29, 2014, Pharmacore, 4180 Mendenhall
Oaks Parkway, High Point, North
Carolina 27265 applied to be registered
as an importer of poppy straw
concentrate (9670), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
intermediates for sale to its customers.
22553
[FR Doc. 2015–09350 Filed 4–21–15; 8:45 am]
BILLING CODE P
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Cedarburg
Pharmaceuticals, Inc.
ACTION:
Notice of registration.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–392]
Cedarburg Pharmaceuticals,
Inc. applied to be registered as a
manufacturer of certain basic classes of
controlled substances. The DEA grants
Cedarburg Pharmaceuticals, Inc.
registration as a manufacturer of the
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated June 10, 2014, and published in
the Federal Register on June 17, 2014,
79 FR 34553, Cedarburg
Pharmaceuticals, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024
applied to be registered as a
SUMMARY:
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Application: Meridian Medical
Technologies
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
May 22, 2015. Such persons may also
file a written request for a hearing on
DATES:
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)]
[Notices]
[Page 22553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09332]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: PHARMACORE
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before May 22, 2015. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before May 22, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODXL,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
Comments and requests for any hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (January 25,
2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispenser, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix of subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on August
29, 2014, Pharmacore, 4180 Mendenhall Oaks Parkway, High Point, North
Carolina 27265 applied to be registered as an importer of poppy straw
concentrate (9670), a basic class of controlled substance listed in
schedule II.
The company plans to import the listed controlled substance to
manufacture bulk controlled substance intermediates for sale to its
customers.
Dated: April 14, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-09332 Filed 4-21-15; 8:45 am]
BILLING CODE 4410-09-P
